GlassScriptPhysician profile
Amit Mohindra
NPI 1427029453
$873.21
in general payments reported to CMS, 2019-2025
19 companies · $372 in 2025
The $372 reported for 2025 was less than what a typical Hematology (Internal Medicine) provider received nationally (typical 2025 total: $1,177).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $16.04 · 2022: $140 · 2024: $45.05 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $219 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.13 |
| Education | $198.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $157.11 | 2019-2025 | Erleada |
| Gilead Sciences, INC. | $99.00 | 2025 | Trodelvy |
| Eisai INC. | $98.91 | 2022 | |
| Genentech USA, INC. | $62.80 | 2022-2025 | Tecentriq, Rozlytrek, Alecensa |
| Astellas Pharma US INC | $59.99 | 2019 | |
| Pfizer INC. | $58.83 | 2019 | |
| Foundation Medicine, INC. | $55.85 | 2019 | |
| Tempus Ai, INC | $55.39 | 2025 | Xt Cdx |
| Novartis Pharmaceuticals Corporation | $45.43 | 2024-2025 | |
| Glaxosmithkline, LLC. | $43.30 | 2025 | Ojjaara |
| Incyte Corporation | $27.92 | 2025 | Monjuvi |
| Seagen INC. | $25.43 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.46 | 2019 | |
| Karyopharm Therapeutics INC. | $16.04 | 2020 | |
| Celgene Corporation | $13.90 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tesaro, INC. | $12.62 | 2019 | |
| Merck Sharp & Dohme LLC | $12.25 | 2019 | |
| Emd Serono, INC. | $10.98 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Mohindra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.